Advanced Renal Cell Carcinoma: Patient-Specific Recommendations From an International Panel of Experts

Gain global perspective on the treatment of advanced RCC in this comprehensive educational program. Evaluate your choice of therapy against a panel of international experts with an Interactive Decision Support Tool or read through the module and ClinicalThought commentary to review strategies for individualized first-line and second-line treatment, the available sequencing treatment, and adverse event management.
Bernard Escudier, MD
person default
James Larkin, PhD, FRCP
Bradley A. McGregor, MD
person default
Michael Staehler, MD, PhD
Cora N. Sternberg, MD, FACP

Interactive Decision Support Tool

This interactive treatment decision aid will let you compare your choice of therapy for patients with advanced RCC with expert recommendations from Bernard Escudier, MD; Bradley A. McGregor, MD; James M. G. Larkin, MD, PhD; Michael Staehler, MD, PhD; and Cora N. Sternberg, MD, FACP. 

Bernard Escudier, MD person default James Larkin, PhD, FRCP Bradley A. McGregor, MD person default Michael Staehler, MD, PhD Cora N. Sternberg, MD, FACP Released: December 1, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
Ipsen Biopharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue